AIDS pacient's long-term battle with multiply recurrent tuberculosis: reinfection or reactivation?

The advent of Mycobacterium tuberculosis strain genotyping has allowed differentiation between disease relapse and exogenous re-infection. We report here a remarkable case of multiply recurrent tuberculosis in a patient living with HIV. Between 1995 and 2009, a young HIV-infected intravenous drug user, who was reluctant to comply with anti-retroviral treatment, underwent at least five tuberculosis episodes caused by three distinct M. tuberculosis strains sharply differentiated by drug susceptibility profile, genotype and infectious source. Eventually, the patient died during a relapse of tuberculosis due to a notorious multidrug-resistant outbreak-strain, which infected him during a prolonged hospitalization in the epicentre of such outbreak. Whether recurrent tuberculosis is due to a new infection or to reactivation of a previous one is a century-long controversial question. In our patient, both conditions alternated throughout his 15 years of living with HIV. Cases such as this might not be exceptional in certain underprivileged suburban areas of Argentina and should raise concern over three pending issues in tuberculosis control policies, namely secondary preventing therapy, institutional infection control and patient follow-up throughout the health network system.

Evaluation of synthetic pseudo cord-factor-like glycolipids for the serodiagnosis of tuberculosis.

A number of glycolipids were evaluated in an ELISA test for their serodiagnostic usefulness in tuberculosis. One hundred and twelve (112) sera belonging to bacteriologically confirmed TB patients, patients with pathologies other than tuberculosis and healthy individuals were examined against several synthetic "mirror" pseudo cord factors (analogues of trehalose-6,6'-dimycolate or TDM) using natural cord factor and another recently described natural glycolipid (SL-IV) of Mycobacterium tuberculosis as control antigens. Analysis of the results shows that all synthetic "mirror" pseudo cord factors, except one with a short 8-carbon chain, were better recognized by the sera of tuberculosis patients than natural cord factor, with sensitivity and specificity values in the ELISA test similar to those reported for M. tuberculosis species-specific SL-IV. Of all antigens tested in this study, BDA. TDA, a bis(N,N-dioctadecylamide) of "trehalose dicarboxylic acid", [(alpha-D-glucopyranosyluronic acid) (alpha-D-glucopyranosiduranic acid)], showed the highest serodiagnostic discriminating power (93% sensitivity and specificity). We postulate that either these artificial molecules are cross-reactants of similarly structured native glycolipids of M. tuberculosis or that they bear closer resemblance to actual phagosome-lysosome-modified antigens than to native mycobacterial ones.

Evaluation of the effectiveness of BCG vaccination using the case-control method in Buenos Aires, Argentina.

A retrospective case-control study was conducted in Argentina to determine the protection conferred by BCG vaccination against tuberculosis in children under six years of age, in an area where coverage is about 55%. A total of 175 tuberculosis patients were included. Five controls selected from patients treated at the same hospital as those under study for reasons other than tuberculosis were matched to each case on the basis of age, socioeconomic origin, nutritional status and place of residence. Information on BCG vaccination status was collected by an independent examiner. Tuberculosis localizations were as follows: 152 pulmonary, pleural and/or miliary; 18 meningitis; 2 lymphadenitis; 2 osteoarticular; and 1 otic. The diagnosis was based on bacteriological and histopathological tests, computerized tomography, radiology, clinical examination, endoscopy, and proved source of infection. The protective effect of BCG among those who were vaccinated was 73.0% with 95% confidence limits of 82% and 62%. According to these results BCG vaccination given early in life is very effective in preventing tuberculosis.

Bovine tuberculosis in Latin America and the Caribbean: current status, control and eradication programs.

Out of the approximately 300 million head which constitute the bovine population in Latin America and the Caribbean, 80 million are found in countries where rates of Mycobacterium bovis infection are very low or nil. The remaining 220 million are found in countries with either a moderate to high prevalence or where no recent information is available. Argentina and Brazil, both have huge cattle populations with estimated prevalences higher than 1%, and together may harbour 3.5 million infected cattle. Information on the impact of M. bovis on human health in the Region is scarce and does not include data on infection of children. In Argentina, human tuberculosis of bovine origin was found to be mainly an occupational disease, transmitted by aerosol. Control or eradication has been achieved in several countries in the Region by use of the tuberculin test followed by sacrifice of reactors. In countries such as Cuba, where the prevalence is already very low, area tuberculin testing is being replaced by slaughter surveillance and epidemiological trace-back. Other countries, where the prevalence is high (e.g. Chile, Paraguay, Peru and Argentina), promote regional campaigns based on the decision and active participation of cattle farmers. Recent diagnostic developments based on the in vitro measurement of humoral and cellular immune responses could be an aid in control and eradication campaigns, provided their usefulness is demonstrated in field trials. In heavily infected areas complementary or alternative strategies should also be proposed, aiming at lowering the prevalence rates prior to the application of the test and slaughter method.

Reciprocal cellular and humoral immune responses in bovine tuberculosis.

A sandwich ELISA for the detection of gamma interferon showed higher sensitivity and specificity than an indirect ELISA for mycobacterial antibodies in the diagnosis of bovine tuberculosis. Circumstantial evidence of an inverse relationship between cellular and humoral immune responses to Mycobacterium bovis was found in cattle with natural infection.

The administration of foot and mouth disease vaccine with oil adjuvant and its influence on the diagnosis of bovine tuberculosis.

The possible influence of vaccination with oil adjuvanted foot and mouth disease vaccines on the tuberculin response was investigated in 32 normal guinea pigs and 190 non-tuberculous bovines. Circulating anti-Mycobacterium bovis IgG antibodies were analysed by an enzyme-linked immunosorbent assay (ELISA), in order to determine the effect of the vaccination on the humoral response against mycobacteria in cattle. Control animals were either nonvaccinated or injected with aluminium hydroxide adjuvanted vaccine. Administration of foot and mouth disease vaccine had no apparent influence on the tuberculin responses of either guinea pigs or cattle, nor did it influence the level of anti-M. bovis antibodies in cattle.

Mycobacteria isolated from nasal secretions of tuberculin test reactor cattle.

Nasal secretions of 103 Holstein cows from a tuberculosis-infected herd in Argentina were bacteriologically cultured for mycobacteria. Mycobacterium bovis was isolated in 8.7% of the cultures. This method was useful for the detection of active tuberculosis with open lesions. Other mycobacteria, most of which grew rapidly on culture media, were isolated in 32% of the cultures and were of little importance as sensitizing agents to mammalian tuberculin in experimental studies in guinea pigs.

[Resistance and multiresistance to antitubercular drugs in Argentina and in other Latin American countries]. / La resistencia y multirresistencia a los medicamentos antituberculosos en la Argentina y en otros países de América Latina.

Resistance of Mycobacterium tuberculosis to both isoniazid (INH) and rifampicin (RPM), the most important antituberculosis drugs, with or without simultaneous resistance to other drugs, is known as multidrug resistance (MDR). It is the main obstacle to attain the cure of patients by the specific treatment, and a threat to the tuberculosis control. Between 1994 and 1997, several Latin American countries undertook countrywide surveys or surveillance programs to determine their primary and acquired drug resistance prevalence rates. These studies followed the WHO/International Union Against Tuberculosis and Lung Diseases (IUATLD) guidelines. Percentages of not previously treated patients with tuberculosis due to MDR strains ranged from null or very small (Uruguay, Cuba, Chile) to 4% or higher (Dominican Republic, Argentina). In Argentina, a remarkable correlation between MDR tuberculosis, AIDS and the assistance in urban reference hospitals for infections diseases was observed. Coincidentally with the survey, nosocomial spread of HIV-related MDR tuberculosis occurred in two of these hospitals situated in Buenos Aires and Rosario. But, at the same time, an alarming emergence of MDR was evidenced among non HIV-infected patients with history of previous antituberculosis treatment. Directly observed treatment (DOT) should be increasingly applied, and drug supply guaranteed. Treatment as well as microscopy services for diagnosis and follow up of patients, should be decentralized from the big specialized hospitals in urban areas to the peripheral health centers, in order to make easier for the patients to attend regularly and receive their medications. These strategies will contribute to increase cure rates and to reduce the tuberculosis transmission.

[Humoral response to mycobacteria in patients with Crohn disease]. / Respuesta humoral a micobacterias en pacientes con enfermedad de Crohn.

The recent recovery of Mycobacterium paratuberculosis from tissues of patients with Crohn's disease has highlighted the possible etiologic role of this microorganism in the disease. However, the immunological evidence generated by various groups supporting this hypothesis is as yet inconclusive. A specific antibody response might be masked in these patients by the wide antigenic homologies prevailing within the genus Mycobacterium. The present study was undertaken with the purpose of exploring the humoral response to M. paratuberculosis in patients with Crohn's disease, by means of a cross-absorption procedure recently proposed for unveiling the presence of specific antibodies in bovine paratuberculosis. Antibodies IgG to M. paratuberculosis were investigated by enzyme-linked immunosorbent assay in 90 serum samples from 17 patients with Crohn's disease, 23 patients with ulcerative colitis an 14 with other bowel diseases. Samples from 86 subjects without bowel disease (healthy individuals and patients with tuberculosis, mycobacterioses and fungal diseases) were also included as controls. The specificity of these antibodies was explored by the absorption of sera with an ubiquitous Mycobacterium (M. phlei). The results were compared to those obtained by similar ELISA tests employing M. avium or M. tuberculosis as antigens. A faint humoral response to M. paratuberculosis and M. tuberculosis was detected in patients with Crohn's disease. Cross-absorption with M. phlei did not disclose a specific response nor was an increase in antibody levels detected in patients studied periodically. Sera from patients with ulcerative colitis and other bowel diseases also showed a slight reaction to mycobacteria.(ABSTRACT TRUNCATED AT 250 WORDS)

Multidrug resistant tuberculosis outbreak in Buenos Aires. DNA fingerprinting analysis of isolates.

In order to determine the possible relationship among HIV patients coinfected with multidrug resistant tuberculosis strains who had been receiving clinical assistance in our Hospital, clinical and epidemiological information from 28 patients was collected. DNA fingerprinting by restriction fragment length polymorphism (RFLP) pattern was performed on the mycobacterial isolates from these patients, using the restriction enzyme Pvull and IS 6110 as genetic marker. A unique RFLP pattern was found in 10 isolates from 10 different patients who had a disease caused by a single strain. Our findings confirm RFLP as a reliable and useful tool to analyze TB transmission.

[Bacteriologic diagnosis of extrapulmonary tuberculosis in a general hospital]. / Diagnostico bacteriologico de tuberculosis extrapulmonar en un hospital general.

In a study performed in a general hospital within a period of 19 months, a total of 233 specimens of extrapulmonary origin and 543 lung secretions were tested for mycobacteria. The biopsy and punction fluid specimens were cultured without previous decontaminating treatment in Lowenstein Jensen, Stonebrink, Middlebrook 7H9, 7H10, 7H11 media and inoculated into guinea pigs (Table 1). Urine and lung secretion specimens were decontaminated and cultured in Lowenstein Jensen and Stonebrink media. No inoculation into guinea pigs was performed with these samples. The percentages of positivity by culture were: 11.2% for all extrapulmonary specimens (15% excluding 66 urine samples) and 22.5% for the lung secretions. Positive results were obtained in direct smear examinations in 82% of all positive-culture lung secretions and in 8% of the extrapulmonary specimens. Inoculation into guinea pigs gave less positive results than cultures. On the basis of the present study, it is recommended to culture every extrapulmonary specimens for mycobacteria. These samples should be processed immediately after collection and, if possible, without previous decontamination to assure the best test sensitivity. Eight percent of the strains obtained from extrapulmonary specimens were typed as M. bovis.

[Evaluation of four antigens for the detection of anti-Mycobacterium bovis antibodies by enzyme immunoassay]. / Evaluación de cuatro antígenos para la detección de anticuerpos anti-Mycobacterium bovis por enzimoinmunoensayo.

An enzyme-linked immunosorbent assay (ELISA) for the diagnosis of bovine tuberculosis through the detection of specific seric antibodies has recently been developed in our laboratory. In order to assess its reproducibility and select the most adequate antigen, four bovine PPDs from different sources were evaluated in parallel: PPD M. bovis strain AN5, CEPANZO standard (CPZ), PPD M. bovis strain AN5, European Economic Community standard (EEC), PPD M. bovis strain AN5, prepared from non heated bacilli, killed by phenol (P) and PPD. M. bovis BCG strain prepared at the Pasteur Institute, Paris (BCG). Sera from 22 healthy cattle from tuberculosis free area and 20 bacteriologically confirmed tuberculous animals were employed in simultaneous assays. Antibody mean and standard deviations from healthy cattle expressed as optical density (OD) values were 45 +/- 22 when CPZ was used as antigen, 24 +/- 10 with EEC, 103 +/- 56 with P and 56 +/- 20 with BCG. Mean O.D. from tuberculous cattle were 588 +/- 158, 510 +/- 234, 782 +/- 138 and 441 +/- 189 with antigens CPZ, EEC, P and BCG respectively. A close correlation was observed when results obtained with EEC and P were compared with that of CPZ (r: 0.97 and 0.94 respectively). A lower specificity was achieved when BCG was used as antigen being also lower its correlation with the results obtained with CPZ (r: 0.87). It is concluded that our ELISA would achieve similar sensitivity and specificity if CPZ, EEC and P were used as antigens. On the other hand, BCG would not be suitable for this assay.

Human tuberculosis caused by Mycobacterium bovis in the United States, Latin America and the Caribbean.

Human tuberculosis (TB) caused by Mycobacterium bovis appears to be rare in most of the region of the Americas, although some localities have reported an unusually high prevalence of M. bovis among human TB cases (e.g., San Diego, CA, USA; parts of Mexico). As surveillance data are lacking in many countries, there is substantial uncertainty regarding actual incidence. M. bovis is most often not identified, as the diagnosis of TB is made by smear microscopy alone or using egg-containing culture media lacking pyruvate. Where human M. bovis cases have been studied in the region, they appear to be associated with ingestion of unpasteurized dairy products, or with airborne acquired infection in animal keepers and meat industry workers from countries where bovine TB remains a problem. Human-to-human transmission of M. bovis does occur, but appears to account for a very small proportion of cases. Efforts to eradicate M. bovis in humans in the Americas should therefore be directed at eradicating the disease in cattle, increasing pasteurization of dairy products and providing education about the dangers of consuming unpasteurized dairy products.